Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Arthritis and Rheumatism
|
September 1, 1982
Cancer in connective tissue disease
K A Black, P J Zilko, R L Dawkins, et al.
The American Journal of Medicine
|
November 1, 1977
Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies
C L Masters, R L Dawkins, P J Zilko, et al.
Australian and New Zealand Journal of Medicine
|
June 1, 1986
Scleromyxedema and inflammatory myopathy: a clinicopathologic study of three patients
J M Harvey, P J Zilko, P S Cheah, et al.
The Australasian Journal of Dermatology
|
April 1, 1975
Atypical Sézary syndrome: "T cell leukaemia" associated with reversible clubbing, acrolysis and infiltration of skin and liver
R L Dawkins, P J Zilko, J M Harper, et al.
The Journal of Rheumatology. Supplement
|
January 1, 1981
Myasthenia gravis and D-penicillamine
R L Dawkins, M J Garlepp, B L McDonald, et al.
Australian and New Zealand Journal of Medicine
|
October 1, 1983
Complement allotyping in SLE: association with C4A null
F T Christiansen, R L Dawkins, G Uko, et al.
Annals of Neurology
|
December 1, 1995
Apolipoprotein E epsilon 4 in inclusion body myositis
M J Garlepp, H Tabarias, F M van Bockxmeer, et al.
Muscle & Nerve
|
December 18, 2001
Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study
B A Phillips, L A Cala, G W Thickbroom, et al.
Diabetologia
|
March 1, 1983
HLA and complement genetic markers in diabetic retinopathy
V J McCann, J McCluskey, P H Kay, et al.
Clinical Neurology and Neurosurgery
|
April 22, 2011
The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype
A Rojana-udomsart, M Needham, Y B Luo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Arthritis and Rheumatism
|
September 1, 1982
Cancer in connective tissue disease
K A Black, P J Zilko, R L Dawkins, et al.
The American Journal of Medicine
|
November 1, 1977
Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies
C L Masters, R L Dawkins, P J Zilko, et al.
Australian and New Zealand Journal of Medicine
|
June 1, 1986
Scleromyxedema and inflammatory myopathy: a clinicopathologic study of three patients
J M Harvey, P J Zilko, P S Cheah, et al.
The Australasian Journal of Dermatology
|
April 1, 1975
Atypical Sézary syndrome: "T cell leukaemia" associated with reversible clubbing, acrolysis and infiltration of skin and liver
R L Dawkins, P J Zilko, J M Harper, et al.
The Journal of Rheumatology. Supplement
|
January 1, 1981
Myasthenia gravis and D-penicillamine
R L Dawkins, M J Garlepp, B L McDonald, et al.
Australian and New Zealand Journal of Medicine
|
October 1, 1983
Complement allotyping in SLE: association with C4A null
F T Christiansen, R L Dawkins, G Uko, et al.
Annals of Neurology
|
December 1, 1995
Apolipoprotein E epsilon 4 in inclusion body myositis
M J Garlepp, H Tabarias, F M van Bockxmeer, et al.
Muscle & Nerve
|
December 18, 2001
Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study
B A Phillips, L A Cala, G W Thickbroom, et al.
Diabetologia
|
March 1, 1983
HLA and complement genetic markers in diabetic retinopathy
V J McCann, J McCluskey, P H Kay, et al.
Clinical Neurology and Neurosurgery
|
April 22, 2011
The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype
A Rojana-udomsart, M Needham, Y B Luo, et al.
Page
of 5